32 related articles for article (PubMed ID: 11490230)
1. Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Belair CD; Yeager TR; Lopez PM; Reznikoff CA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13677-82. PubMed ID: 9391085
[TBL] [Abstract][Full Text] [Related]
2. A Rare Epicardial Cytokeratin-Positive Interstitial Reticulum Cell Tumor.
Murao M; Norikane T; Yamamoto Y; Nishiyama Y
Korean Circ J; 2023 Dec; 53(12):858-859. PubMed ID: 38111264
[No Abstract] [Full Text] [Related]
3. Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.
Peng L; Li J; Meng C; Li J; Tang D; Guan F; Xu P; Wei T; Li Y
Front Oncol; 2020; 10():570127. PubMed ID: 33344230
[TBL] [Abstract][Full Text] [Related]
4. Urine cytology and adjunct markers for detection and surveillance of bladder cancer.
Sullivan PS; Chan JB; Levin MR; Rao J
Am J Transl Res; 2010 Jul; 2(4):412-40. PubMed ID: 20733951
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of urinary markers for bladder cancer detection and monitoring.
Shariat SF; Karam JA; Lotan Y; Karakiewizc PI
Rev Urol; 2008; 10(2):120-35. PubMed ID: 18660854
[TBL] [Abstract][Full Text] [Related]
6. Early bladder cancer: concept, diagnosis, and management.
Kitamura H; Tsukamoto T
Int J Clin Oncol; 2006 Feb; 11(1):28-37. PubMed ID: 16508726
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive methods of bladder cancer detection.
Little B
Int Urol Nephrol; 2003; 35(3):331-43. PubMed ID: 15160535
[TBL] [Abstract][Full Text] [Related]
8. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
9. Telomerase in urological malignancy.
Orlando C; Gelmini S; Selli C; Pazzagli M
J Urol; 2001 Aug; 166(2):666-73. PubMed ID: 11458114
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
13. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
15. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
